ទំព័រដើម › Non-Small Cell Lung Cancer › កាលីហ្វ័រញ៉ា › Santa Monica
ការសាកល្បងគ្លីនិកសម្រាប់ Non-Small Cell Lung Cancer នៅក្នុង Santa Monica, CA
ការសិក្សាចំនួន 45 សម្រាប់ Non-Small Cell Lung Cancer កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Santa Monica (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Beverly Hills Cancer Center ( Site 0116), Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study of ZW251 in Participants With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of California Los Angeles - Cancer Care - Santa Monica (UCLA), Santa Monica
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
កំពុងជ្រើសរើសដំណាក់កាល 3
- Tower Cancer Research Foundation, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
- Cedars-Sinai Cancer - Tarzana, Tarzana · ឆ្ងាយ 11 ម៉ាយ
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- UCLA - Santa Monica /ID# 271690, Santa Monica
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
កំពុងជ្រើសរើសដំណាក់កាល 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · ឆ្ងាយ 12 ម៉ាយ
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
កំពុងជ្រើសរើសដំណាក់កាល 3
- Clinical Research Advisors, LLC, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
កំពុងជ្រើសរើសដំណាក់កាល 3
- Tower Cancer Research Foundation, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Beverly Hills Cancer Center, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- ALX Center 11, Santa Monica
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- Research Site, Santa Monica
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Beverly Hills Cancer Center ( Site 0070), Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- UCLA Medical Center, Santa Monica
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Precision NextGen Oncology, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Kivu Trial Site, Santa Monica
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
កំពុងជ្រើសរើសដំណាក់កាល 3
- Research Site, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
កំពុងជ្រើសរើសដំណាក់កាល 3
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Research Site, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
កំពុងជ្រើសរើសដំណាក់កាល 3
- Clinical Study Site, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
កំពុងជ្រើសរើសដំណាក់កាល 3
- Sarcoma Oncology Center, Santa Monica
- University of California Los Angeles, Santa Monica
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- UCLA, Santa Monica
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- UCLA Health - Santa Monica Cancer Care, Santa Monica
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Research Site, Santa Monica
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- UCLA - David Geffen School of Medicine, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of California, Los Angeles (UCLA), Santa Monica
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Cedars-Sinai Cancer at Beverly Hills (THO), Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- UCLA Healthcare Hematology-Oncology, Santa Monica
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Research Site, Santa Monica
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Sarcoma Oncology Center, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Tower Cancer Research Foundation, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- UCLA, Santa Monica
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Tower Cancer Research Foundation, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
- Cedars-Sinai Cancer - Tarzana, Tarzana · ឆ្ងាយ 11 ម៉ាយ
- Kaiser Permanente-Woodland Hills, Woodland Hills · ឆ្ងាយ 12 ម៉ាយ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Tower Cancer Research Foundation, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
- Cedars-Sinai Cancer - Tarzana, Tarzana · ឆ្ងាយ 11 ម៉ាយ
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
កំពុងជ្រើសរើសដំណាក់កាល 2
- Precision NextGen Oncology and Research Center, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
កំពុងជ្រើសរើស
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · ឆ្ងាយ 4 ម៉ាយ
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Research Site 128, Santa Monica
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Precision NextGen Oncology, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
កំពុងជ្រើសរើសដំណាក់កាល 1
- Beverly Hills Cancer Center, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Precision NextGen Oncology, Beverly Hills · ឆ្ងាយ 6 ម៉ាយ
ការសាកល្បងសម្រាប់ Non-Small Cell Lung Cancer នៅក្នុងទីក្រុងផ្សេងទៀត
- Houston, TXការសិក្សា 145
- New York City, NYការសិក្សា 121
- Arlington, VAការសិក្សា 104
- Nashville, TNការសិក្សា 97
- Boston, MAការសិក្សា 90
- Los Angeles, CAការសិក្សា 87
- St. Louis, MOការសិក្សា 73
- Chicago, ILការសិក្សា 61
- Baltimore, MDការសិក្សា 60
- San Antonio, TXការសិក្សា 59
- Columbus, OHការសិក្សា 57
- Washington, DCការសិក្សា 55
ការសិក្សាផ្សេងទៀតនៅក្នុង Santa Monica
- មហារីកទ្រូងការសិក្សា 28
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 23
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 22
- មហារីកដែលរីករាលដាលការសិក្សា 19
- មហារីកសួតការសិក្សា 15
- មហារីកស៊ុតការសិក្សា 15
- មហារីកតូចការសិក្សា 15
- មហារីកកោសិកាស្រអាប់នៅក្បាល និងបំបៅកការសិក្សា 13
- បេះដូងខ្សោយការសិក្សា 11
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 10
- មហារីកក្រពះការសិក្សា 9
- មហារីកតំបក់ការសិក្សា 9
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។